CD73

CD73 詳細

英語名5'-nucleotidase市販薬剤の数0
治験薬の数36ターゲットの別称5' Nucleotidase (CD73),5'-nucleotidase,5'-Nucleotidase, Ecto (CD73),Ecto-5'-nucleotidase,NT5E,5'-Nucleotidase Ecto,Ecto-5-Nucleotidase,5-NT,Purine 5-Prime-Nucleotidase,5-Nucleotidase, Ecto (CD73),5 Nucleotidase (CD73),5-Nucleotidase Ecto,5-Nucleotidase,CD73 Antigen,EC 3.1.3.5,CALJA,E5NT,ENT,NT,EN,CD73,5'-NT,NT5,NTE,EC:3.1.3.5
研究&開発段階Phase 3 Clinical
英語名5'-nucleotidase
ターゲットの別称5' Nucleotidase (CD73),5'-nucleotidase,5'-Nucleotidase, Ecto (CD73),Ecto-5'-nucleotidase,NT5E,5'-Nucleotidase Ecto,Ecto-5-Nucleotidase,5-NT,Purine 5-Prime-Nucleotidase,5-Nucleotidase, Ecto (CD73),5 Nucleotidase (CD73),5-Nucleotidase Ecto,5-Nucleotidase,CD73 Antigen,EC 3.1.3.5,CALJA,E5NT,ENT,NT,EN,CD73,5'-NT,NT5,NTE,EC:3.1.3.5
市販薬剤の数0
治験薬の数36
研究&開発段階Phase 3 Clinical

CD73 製品リスト

  • 属性

    Protein (8)Antibody (2)

  • 製品ライブラリ

    オンライン (10)

  • Human (3)Mouse (3)Cynomolgus (1)Canine (1)Rabbit (1)Rat (1)

  • タグ

    His Tag (6)His Tag & Avi Tag (1)Mouse IgG Fc Tag (1)- (2)

  • マーカー

    Unconjugated (7)Biotin-labeled (1)PE Labeled (1)APC Labeled (1)

CD73バックグランド

5'-nucleotidase (5'-NT), also known as ecto-5'-nucleotidase or CD73 (cluster of differentiation 73), is an enzyme that is encoded by the NT5E gene. CD73 commonly serves to convert AMP to adenosine. Ecto-5-prime-nucleotidase (5-prime-ribonucleotide phosphohydrolase) catalyzes the conversion at neutral pH of purine 5-prime mononucleotides to nucleosides, the preferred substrate being AMP. Other forms of 5-prime nucleotidase exist in the cytoplasm and lysosomes and can be distinguished from ecto-NT5 by their substrate affinities, requirement for divalent magnesium ion, activation by ATP, and inhibition by inorganic phosphate. Rare allelic variants are associated with a syndrome of adult-onset calcification of joints and arteries (CALJA) affecting the iliac, femoral, and tibial arteries reducing circulation in the legs and the joints of the hands and feet causing pain.

CD73分子の別称

CD73,NT5E,5'-Nucleotidase,5'-NT,NT5,NTE

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
UliledlimabTJD-5; TJ-004309; TJ-4309Phase 3 ClinicalI-Mab Biopharma Co LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
詳細
QuemliclustatAB-680Phase 3 ClinicalArcus Biosciences IncAdenocarcinoma; Bile Duct Neoplasms; Biliary Tract Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colorectal Neoplasms; Hormone-Resistant Prostate Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
詳細
OleclumabMEDI-9447Phase 3 ClinicalMedimmune LlcAdenocarcinoma; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Colorectal Neoplasms; Fallopian Tube Neoplasms; Hemangiosarcoma; Liposarcoma; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms
詳細
Dalutrafusp alfaGS-1423; AGEN-1423Phase 2 ClinicalAgenus IncCarcinoma, Pancreatic Ductal; Colorectal Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours
詳細
BMS-986179BMS-986179Phase 2 ClinicalBristol-Myers Squibb CompanySolid tumours
詳細
MupadolimabCPX-006; COR-004 (Corvus Pharmaceuticals); CPI-006Phase 2 ClinicalCorvus Pharmaceuticals IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Endometrial Neoplasms; Head and Neck Neoplasms; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Papillomavirus Infections; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
詳細
XW-LTH-03XW-LTH-03Phase 2 ClinicalShanghai SinoBay Biotechnology Co LtdStomach Neoplasms
詳細
CD73/AXL.HypoSti.CAR-T cells therapy (Pla General Hospital)Phase 2 ClinicalPla General HospitalSolid tumours
詳細
DresbuxelimabAK-119Phase 2 ClinicalCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis; Solid tumours
詳細
GI-108GI-108Phase 2 ClinicalGI Innovation IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Neoplasms; Pancreatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
S-095024S-095024; S095024Phase 2 ClinicalInstitut De Recherches Internationales Servier, Regeneron Pharmaceuticals Inc, Servier Bio-Innovation LLCCarcinoma, Non-Small-Cell Lung
詳細
HB-0052HB0052; HB-0052Phase 2 ClinicalShanghai Huaota Biopharmaceutical Co Ltd, Zhejiang Huahai Pharmaceutical Co LtdPancreatic Neoplasms; Solid tumours
詳細
HB-0045HB-0045; HB0045Phase 2 ClinicalHuaBo Biopharm Co Ltd, Shanghai Huaota Biopharmaceutical Co LtdSolid tumours
詳細
JAB-BX102JAB-BX102Phase 2 ClinicalJacobio Pharmaceuticals Co LtdSolid tumours
詳細
PT-199PT-199Phase 2 ClinicalPhanes Therapeutics IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Solid tumours
詳細
LY-3475070LY-3475070Phase 1 ClinicalEli Lilly And CompanyNeoplasms
詳細
Anti-CD73 monoclonal antibody (Bristol-Myers Squibb)Phase 1 ClinicalBristol-Myers Squibb CompanyNeoplasms
詳細
AP-601AP-601Phase 1 ClinicalAP Biosciences IncNeoplasms; Solid tumours
詳細
68Ga-dPNE68Ga-dPNEPhase 1 ClinicalFirst Affiliated Hospital Of Fujian Medical UniversityNeoplasms
詳細
AK-137AK137; AK-137Phase 1 ClinicalNeoplasms
詳細
68GA-DOTA-dPNE68GA-DOTA-dPNEPhase 1 ClinicalPeking Union Medical College HospitalBreast Neoplasms
詳細
LNF-2008LNF-2008; LNF2008Phase 1 ClinicalShandong New Time Pharmaceutical Co LtdSolid tumours
詳細
HB-0046HB0046; HB-0046Phase 1 ClinicalHuaBo Biopharm Co Ltd, Shanghai Huaota Biopharmaceutical Co LtdSolid tumours
詳細
SYS-6011SYS6011; SYS-6011Phase 1 ClinicalJushi Biopharmaceutical Co LtdSolid tumours
詳細
BPI-472372BPI-472372Phase 1 ClinicalBetta Pharmaceuticals Co LtdSolid tumours
詳細
BB-1709BB-1709Phase 1 ClinicalBliss Biopharmaceutical (Hangzhou) Co LtdSolid tumours
詳細
PM-1015PM1015; PM-1015Phase 1 ClinicalSolid tumours
詳細
AK-131AK-131Phase 1 ClinicalNeoplasms; Solid tumours
詳細
IBI-325IBI-325Phase 1 ClinicalSolid tumours
詳細
BR-101BR101; BR-101Phase 1 ClinicalZhejiang BioRay Biopharmaceuticals Co LtdSolid tumours
詳細
CB-708ATG-037; ATN-037; CB-708; CB708Phase 1 ClinicalCalithera Biosciences IncCarcinoma, Non-Small-Cell Lung; Melanoma; Neoplasms; Solid tumours
詳細
HLX-23HLX-23Phase 1 ClinicalLymphoma; Solid tumours
詳細
ORIC533ORIC-533Phase 1 ClinicalOric Pharmaceuticals IncMultiple Myeloma; Neoplasm Metastasis
詳細
IPH-5301IPH-5301Phase 1 ClinicalInnate PharmaBreast Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Lung Neoplasms; Metastatic breast cancer; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
HBM-1007HBM1007; R 1007; HBM 1007; HBM-1007Phase 1 ClinicalHarbour BiomedNeoplasms; Solid tumours
詳細
ABSK-051ABSK051Phase 1 ClinicalABbisko Therapeutics Co LtdNeoplasms; Solid tumours
詳細

レビュー

  • H***g2021-11-29
    0評価
    It was used in research of investgational new drugs. Specifically, I have used this product in my Epitope binning experiments (using Octet) and I am truely satisfied with the results. With this experiment and your product, we have found a approximate epitope binding site. Thanks for your highly qualified product.
  • 詳細
  • 製品リスト
  • レビュー
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8